Longevity Health Holdings, Inc. (XAGE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 200K 400K 600K Q3 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 12.3K Q3 '24: 20.5K Q4 '24: 17.5K Q1 '25: 510.4K Q2 '25: 503.6K Q3 '25: 425.9K Q4 '25: 473K Q1 '26: 391.8K Q2 '26: 396K Q3 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 150K 300K 450K Q3 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 12K Q3 '24: 15.7K Q4 '24: 16.3K Q1 '25: 269.8K Q2 '25: 302.7K Q3 '25: 254.5K Q4 '25: 267.8K Q1 '26: 237K Q2 '26: 235.5K Q3 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-3M -2M -1M 0 1M 2M 3M Q2 '21: -6.4K Q3 '21: -90K Q4 '21: -369.9K Q1 '22: -535.1K Q2 '22: -285.9K Q3 '22: -851.9K Q4 '22: -2.8M Q1 '23: -1.3M Q2 '23: -1.5M Q3 '23: -2.8M Q4 '23: -333K Q1 '24: -1.4M Q2 '24: -1.2M Q3 '24: -1.4M Q4 '24: -1M Q1 '25: -1.5M Q2 '25: -1.9M Q3 '25: -1.5M Q4 '25: -2.3M Q1 '26: -1.3M Q2 '26: -724.1K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q2 '21: -6.4K Q3 '21: 42.7K Q4 '21: -364.5K Q1 '22: -527.5K Q2 '22: -347K Q3 '22: -6.1M Q4 '22: -3.1M Q1 '23: -1.8M Q2 '23: -5.3M Q3 '23: -11.5M Q4 '23: -8.9K Q1 '24: -3.3M Q2 '24: -3.3M Q3 '24: -2.9M Q4 '24: -914.3K Q1 '25: -1.5M Q2 '25: -1.9M Q3 '25: -1.4M Q4 '25: -2.1M Q1 '26: -1.4M Q2 '26: -1.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 90K 180K 270K Q3 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 292 Q3 '24: 4.8K Q4 '24: 1.2K Q1 '25: 240.5K Q2 '25: 201K Q3 '25: 171.4K Q4 '25: 205.2K Q1 '26: 154.7K Q2 '26: 160.5K Q3 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -373.9K Q4 '21: -70.9K Q1 '22: -151.7K Q2 '22: -43.2K Q3 '22: -934.6K Q4 '22: -2.3M Q1 '23: -476K Q2 '23: -480.2K Q3 '23: -4M Q4 '23: -3.4M Q1 '24: -1.1M Q2 '24: -1.1M Q3 '24: -906.9K Q4 '24: -772.1K Q1 '25: -753K Q2 '25: -836.2K Q3 '25: -1.4M Q4 '25: -306.4K Q1 '26: -485.3K Q2 '26: -223.9K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '22: -2.3M Q3 '23: -4M Q4 '23: -3.4M Q4 '25: -306.4K Q4 '22 Q3 '23 Q4 '23 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 7M 14M 21M Q3 '21: 3.8M Q3 '22: 913.7K Q1 '23: 1.1M Q2 '23: 1.1M Q3 '23: 18.6M Q1 '24: 763.8K Q2 '24: 691.2K Q3 '24: 696.8K Q1 '25: 991.2K Q2 '25: 1.2M Q3 '25: 1.7M Q1 '26: 1.9M Q2 '26: 2.5M Q3 '21 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q2 '23: -15.38 Q3 '23: -9.26 Q4 '23: -1.46 Q1 '24: -3.83 Q2 '24: -3.61 Q3 '24: -7.12 Q4 '24: -14.56 Q1 '25: -11.80 Q2 '25: -8.58 Q3 '25: -5.28 Q4 '25: -5.06 Q1 '26: -4.29 Q2 '26: -3.49 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.